Commercial Disinfectants During Disinfection Process Validation: More Failures than Success
Introduction: Disinfection process validation is mandatory before introduction of a new disinfectant in hospital services. Commercial disinfection brands often question existing hospital policy claiming greater efficacy and lack of toxicity of their products. Inadvertent inadequate disinfection...
Main Authors: | , , |
---|---|
Format: | Article |
Language: | English |
Published: |
JCDR Research and Publications Private Limited
2016-08-01
|
Series: | Journal of Clinical and Diagnostic Research |
Subjects: | |
Online Access: | https://jcdr.net/articles/PDF/8363/20290_CE[Ra]_F(P)_PF1(ASESAK)_PFA(AK).pdf |
Summary: | Introduction: Disinfection process validation is mandatory
before introduction of a new disinfectant in hospital services.
Commercial disinfection brands often question existing hospital
policy claiming greater efficacy and lack of toxicity of their
products. Inadvertent inadequate disinfection leads to morbidity,
patient’s economic burden, and the risk of mortality.
Aim: To evaluate commercial disinfectants for high, intermediate
and low-level disinfection so as to identify utility for our routine
situations.
Materials and Methods: This laboratory based experiment was
conducted at St Stephen Hospital, Delhi during July-September
2013. Twelve commercial disinfectants: Sanidex®, Sanocid®,
Cidex®, SekuSept Aktiv®, BIB Forte®, Alprojet W®, Desnet®,
Sanihygiene®, Incidin®, D125®, Lonzagard®, and Glutishield®
were tested. Time-kill assay (suspension test) was performed
against six indicator bacteria (Escherichia coli, Staphylococcus
aureus, Pseudomonas aeruginosa, Salmonella Typhi, Bacillus
cereus, and Mycobacterium fortuitum). Low and high inoculum
(final concentrations 1.5X106
and 9X106
cfu/ml) of the first five
bacteria while only low level of M. fortuitum was tested.
Results: Cidex® (2.4% Glutaraldehyde) performed best as
high level disinfectant while newer quarternary ammonium
compounds (QACs) (Incidin®, D125®, and Lonzagard®)
were good at low level disinfection. Sanidex® (0.55% Orthopthalaldehyde) though mycobactericidal took 10 minutes
for sporicidal activity. Older QAC containing BIB Forte® and
Desnet® took 20 minutes to fully inhibit P. aeruginosa. All
disinfectants effectively reduced S. Typhi to zero counts within
5 minutes.
Conclusion: Cidex® is a good high-level disinfectant while
newer QACs (Incidin®, D125®, and Lonzagard®) were capable
low-level disinfectants. |
---|---|
ISSN: | 2249-782X 0973-709X |